QUICK READ: There was hope that all the negativity towards pharma would start to evaporate as they worked on a vaccine for COVID-19 but that goodwill is being eroded by…
Category: Bad practices
Gilead is always about money
QUICK READ: Gilead could reap billions from the sales of Remdesivir. Although Remdesivir is the only therapy so far to show a slight impact in helping hospitalized Covid-19 patients a…
Investors react to irresponsible news
QUICK READ: STAT News post entitled “Early peek at data on Gilead drug suggests patients are responding to treatment” was irresponsible and had led to investors gambling on a drug…
Pharma struggling with digital
QUICK READ: Just as I had written on this site a Chief Digital Officer for a top pharma company has left after just twenty-four months on the job. Culture destroys…
Drugmakers great new year with price increases
SUMMARY: Happy new year! Here’s a 4-6% price increase on your prescription drug. Prescription drug prices are sure to be on the political talking points as drug makers indicate that…
What’s really wrong with pharma is free-market capitalism
SUMMARY: Free-market capitalism is in trouble. The focus on “profits now” is leading to a mentality of short-term business practices that are harming our health and well-being for the sake…
A pharma salespersons confession
SUMMARY: The “confession” from a former Eli Lilly salesperson is indeed damning but shouldn’t be an indictment of ALL salespeople. However, as more and more HCP’s decline to see salespeople…
DTC is not working anymore
WHAT”S GOING ON: DTC TV ads aren’t working. There are too many barriers to get people to ask for or switch to new treatments. Even with improved benefits, most patients…